Boisguérin et al., 2015 - Google Patents
Delivery of therapeutic oligonucleotides with cell penetrating peptidesBoisguérin et al., 2015
View PDF- Document ID
- 3833441656388558562
- Author
- Boisguérin P
- Deshayes S
- Gait M
- O'Donovan L
- Godfrey C
- Betts C
- Wood M
- Lebleu B
- Publication year
- Publication venue
- Advanced drug delivery reviews
External Links
Snippet
Oligonucleotide-based drugs have received considerable attention for their capacity to modulate gene expression very specifically and as a consequence they have found applications in the treatment of many human acquired or genetic diseases. Clinical …
- 229920000272 Oligonucleotide 0 title abstract description 83
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boisguérin et al. | Delivery of therapeutic oligonucleotides with cell penetrating peptides | |
| Yin et al. | Protein based therapeutic delivery agents: contemporary developments and challenges | |
| Vhora et al. | Protein–and peptide–drug Conjugates: An emerging drug delivery technology | |
| CL2019003842A1 (en) | Recombinant viral vectors with modified tropism and uses of these for the targeted introduction of genetic material into human cells. | |
| PH12021550307A1 (en) | T Cell Receptor Constructs And Uses Thereof | |
| AR129651A2 (en) | OPTIMIZATION OF ANTIBODIES THAT BIND TO LYMPHOCYTE ACTIVATION GENE 3 (LAG-3) AND THEIR USES | |
| MX2015011393A (en) | Modified poly(beta-amino ester)s for drug delivery. | |
| EP4257675A3 (en) | Delivery of materials to anucleate cells | |
| MX2020000903A (en) | Anti-cd8 antibodies and uses thereof. | |
| EA202090956A3 (en) | ANTIBODIES TO CD73 AND THEIR APPLICATIONS | |
| EP4249036A3 (en) | Methods and products for nucleic acid production and delivery | |
| WO2014179331A3 (en) | Devices, systems and methods for optogenetic modulation of action potentials in target cells | |
| WO2014066915A3 (en) | Methods and compositions to produce ss-rnai activity with enhanced potency | |
| Álvarez et al. | Antigen targeting to APC: from mice to veterinary species | |
| IN2014CN04734A (en) | ||
| Neesse et al. | Emerging role of microRNAs to tackle drug resistance in pancreatic cancer | |
| NZ789437A (en) | Chimeric opsin gpcr proteins | |
| MX2015005867A (en) | C4s proteoglycan specific transporter molecules. | |
| AR102762A1 (en) | SEQUENCE OF OLIGONUCLEOTIDES FOR USE IN METABOLIC ROUTE ENGINEERING | |
| WO2014006452A3 (en) | Rapid alkalinization factor peptides for delivery of nucleic acid molecules into cells | |
| WO2007124452A3 (en) | Methods for expressing multiple sirna and shrna from a single vector | |
| Reynolds et al. | C55 ADVANCES IN PULMONARY VASCULAR CELL BIOLOGY: Adenoviral Delivered Bmpr2 Downregulates Tgf-ß Signalling In Human Pulmonary Smooth Muscle Cells | |
| Wicks et al. | RNAi2011: Gene Regulation by Small RNAs | |
| Yoojin et al. | Structural Analysis of an Adeno-associated Virus Variant Promoting Immune Resistance and Robust Gene Delivery | |
| Vidovic et al. | Peptide-polymer conjugates as tools to selectively target EGFR |